Table of Content

1 Oncology Radiopharmaceutical Market Overview
1.1 Product Overview and Scope of Oncology Radiopharmaceutical
1.2 Oncology Radiopharmaceutical Segment by Type
1.2.1 Global Oncology Radiopharmaceutical Market Value Comparison by Type (2024-2034)
1.2.2 Oral Drugs
1.2.3 Intravenous Drugs
1.2.4 Other
1.3 Oncology Radiopharmaceutical Segment by Application
1.3.1 Global Oncology Radiopharmaceutical Market Value by Application: (2024-2034)
1.3.2 Hospitals and Clinics
1.3.3 Pharmaceutical Company
1.3.4 Research Center
1.3.5 Other
1.4 Global Oncology Radiopharmaceutical Market Size Estimates and Forecasts
1.4.1 Global Oncology Radiopharmaceutical Revenue 2018-2034
1.4.2 Global Oncology Radiopharmaceutical Sales 2018-2034
1.4.3 Global Oncology Radiopharmaceutical Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Oncology Radiopharmaceutical Market Competition by Manufacturers
2.1 Global Oncology Radiopharmaceutical Sales Market Share by Manufacturers (2018-2024)
2.2 Global Oncology Radiopharmaceutical Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Oncology Radiopharmaceutical Average Price by Manufacturers (2018-2024)
2.4 Global Oncology Radiopharmaceutical Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Oncology Radiopharmaceutical, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncology Radiopharmaceutical, Product Type & Application
2.7 Oncology Radiopharmaceutical Market Competitive Situation and Trends
2.7.1 Oncology Radiopharmaceutical Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oncology Radiopharmaceutical Players Market Share by Revenue
2.7.3 Global Oncology Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oncology Radiopharmaceutical Retrospective Market Scenario by Region
3.1 Global Oncology Radiopharmaceutical Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Oncology Radiopharmaceutical Global Oncology Radiopharmaceutical Sales by Region: 2018-2034
3.2.1 Global Oncology Radiopharmaceutical Sales by Region: 2018-2024
3.2.2 Global Oncology Radiopharmaceutical Sales by Region: 2024-2034
3.3 Global Oncology Radiopharmaceutical Global Oncology Radiopharmaceutical Revenue by Region: 2018-2034
3.3.1 Global Oncology Radiopharmaceutical Revenue by Region: 2018-2024
3.3.2 Global Oncology Radiopharmaceutical Revenue by Region: 2024-2034
3.4 North America Oncology Radiopharmaceutical Market Facts & Figures by Country
3.4.1 North America Oncology Radiopharmaceutical Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Oncology Radiopharmaceutical Sales by Country (2018-2034)
3.4.3 North America Oncology Radiopharmaceutical Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oncology Radiopharmaceutical Market Facts & Figures by Country
3.5.1 Europe Oncology Radiopharmaceutical Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Oncology Radiopharmaceutical Sales by Country (2018-2034)
3.5.3 Europe Oncology Radiopharmaceutical Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oncology Radiopharmaceutical Market Facts & Figures by Country
3.6.1 Asia Pacific Oncology Radiopharmaceutical Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Oncology Radiopharmaceutical Sales by Country (2018-2034)
3.6.3 Asia Pacific Oncology Radiopharmaceutical Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oncology Radiopharmaceutical Market Facts & Figures by Country
3.7.1 Latin America Oncology Radiopharmaceutical Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Oncology Radiopharmaceutical Sales by Country (2018-2034)
3.7.3 Latin America Oncology Radiopharmaceutical Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oncology Radiopharmaceutical Market Facts & Figures by Country
3.8.1 Middle East and Africa Oncology Radiopharmaceutical Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Oncology Radiopharmaceutical Sales by Country (2018-2034)
3.8.3 Middle East and Africa Oncology Radiopharmaceutical Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oncology Radiopharmaceutical Sales by Type (2018-2034)
4.1.1 Global Oncology Radiopharmaceutical Sales by Type (2018-2024)
4.1.2 Global Oncology Radiopharmaceutical Sales by Type (2024-2034)
4.1.3 Global Oncology Radiopharmaceutical Sales Market Share by Type (2018-2034)
4.2 Global Oncology Radiopharmaceutical Revenue by Type (2018-2034)
4.2.1 Global Oncology Radiopharmaceutical Revenue by Type (2018-2024)
4.2.2 Global Oncology Radiopharmaceutical Revenue by Type (2024-2034)
4.2.3 Global Oncology Radiopharmaceutical Revenue Market Share by Type (2018-2034)
4.3 Global Oncology Radiopharmaceutical Price by Type (2018-2034)
5 Segment by Application
5.1 Global Oncology Radiopharmaceutical Sales by Application (2018-2034)
5.1.1 Global Oncology Radiopharmaceutical Sales by Application (2018-2024)
5.1.2 Global Oncology Radiopharmaceutical Sales by Application (2024-2034)
5.1.3 Global Oncology Radiopharmaceutical Sales Market Share by Application (2018-2034)
5.2 Global Oncology Radiopharmaceutical Revenue by Application (2018-2034)
5.2.1 Global Oncology Radiopharmaceutical Revenue by Application (2018-2024)
5.2.2 Global Oncology Radiopharmaceutical Revenue by Application (2024-2034)
5.2.3 Global Oncology Radiopharmaceutical Revenue Market Share by Application (2018-2034)
5.3 Global Oncology Radiopharmaceutical Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Novartis Oncology Radiopharmaceutical Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Chimeric Therapeutics Limited
6.2.1 Chimeric Therapeutics Limited Corporation Information
6.2.2 Chimeric Therapeutics Limited Description and Business Overview
6.2.3 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Portfolio
6.2.5 Chimeric Therapeutics Limited Recent Developments/Updates
6.3 Fusion Pharma
6.3.1 Fusion Pharma Corporation Information
6.3.2 Fusion Pharma Description and Business Overview
6.3.3 Fusion Pharma Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Fusion Pharma Oncology Radiopharmaceutical Product Portfolio
6.3.5 Fusion Pharma Recent Developments/Updates
6.4 Lantheus Medical lmaging, Inc.
6.4.1 Lantheus Medical lmaging, Inc. Corporation Information
6.4.2 Lantheus Medical lmaging, Inc. Description and Business Overview
6.4.3 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Portfolio
6.4.5 Lantheus Medical lmaging, Inc. Recent Developments/Updates
6.5 NanoMab
6.5.1 NanoMab Corporation Information
6.5.2 NanoMab Description and Business Overview
6.5.3 NanoMab Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
6.5.4 NanoMab Oncology Radiopharmaceutical Product Portfolio
6.5.5 NanoMab Recent Developments/Updates
6.6 NuView Life Sciences.
6.6.1 NuView Life Sciences. Corporation Information
6.6.2 NuView Life Sciences. Description and Business Overview
6.6.3 NuView Life Sciences. Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
6.6.4 NuView Life Sciences. Oncology Radiopharmaceutical Product Portfolio
6.6.5 NuView Life Sciences. Recent Developments/Updates
6.7 PentixaPharm GmbHPrecirix
6.6.1 PentixaPharm GmbHPrecirix Corporation Information
6.6.2 PentixaPharm GmbHPrecirix Description and Business Overview
6.6.3 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
6.4.4 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Portfolio
6.7.5 PentixaPharm GmbHPrecirix Recent Developments/Updates
6.8 RadioMedix
6.8.1 RadioMedix Corporation Information
6.8.2 RadioMedix Description and Business Overview
6.8.3 RadioMedix Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
6.8.4 RadioMedix Oncology Radiopharmaceutical Product Portfolio
6.8.5 RadioMedix Recent Developments/Updates
6.9 RayzeBio
6.9.1 RayzeBio Corporation Information
6.9.2 RayzeBio Description and Business Overview
6.9.3 RayzeBio Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
6.9.4 RayzeBio Oncology Radiopharmaceutical Product Portfolio
6.9.5 RayzeBio Recent Developments/Updates
6.10 Telix Pharmaceuticals Limited
6.10.1 Telix Pharmaceuticals Limited Corporation Information
6.10.2 Telix Pharmaceuticals Limited Description and Business Overview
6.10.3 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Portfolio
6.10.5 Telix Pharmaceuticals Limited Recent Developments/Updates
6.11 Theragnostics Ltd
6.11.1 Theragnostics Ltd Corporation Information
6.11.2 Theragnostics Ltd Oncology Radiopharmaceutical Description and Business Overview
6.11.3 Theragnostics Ltd Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Theragnostics Ltd Oncology Radiopharmaceutical Product Portfolio
6.11.5 Theragnostics Ltd Recent Developments/Updates
6.12 Vect-Horus
6.12.1 Vect-Horus Corporation Information
6.12.2 Vect-Horus Oncology Radiopharmaceutical Description and Business Overview
6.12.3 Vect-Horus Oncology Radiopharmaceutical Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Vect-Horus Oncology Radiopharmaceutical Product Portfolio
6.12.5 Vect-Horus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oncology Radiopharmaceutical Industry Chain Analysis
7.2 Oncology Radiopharmaceutical Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oncology Radiopharmaceutical Production Mode & Process
7.4 Oncology Radiopharmaceutical Sales and Marketing
7.4.1 Oncology Radiopharmaceutical Sales Channels
7.4.2 Oncology Radiopharmaceutical Distributors
7.5 Oncology Radiopharmaceutical Customers
8 Oncology Radiopharmaceutical Market Dynamics
8.1 Oncology Radiopharmaceutical Industry Trends
8.2 Oncology Radiopharmaceutical Market Drivers
8.3 Oncology Radiopharmaceutical Market Challenges
8.4 Oncology Radiopharmaceutical Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Oncology Radiopharmaceutical Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Oncology Radiopharmaceutical Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Oncology Radiopharmaceutical Market Competitive Situation by Manufacturers in 2022
Table 4. Global Oncology Radiopharmaceutical Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Oncology Radiopharmaceutical Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Oncology Radiopharmaceutical Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Oncology Radiopharmaceutical Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Oncology Radiopharmaceutical Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Oncology Radiopharmaceutical, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Oncology Radiopharmaceutical, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oncology Radiopharmaceutical, Product Type & Application
Table 12. Global Key Manufacturers of Oncology Radiopharmaceutical, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oncology Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Radiopharmaceutical as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oncology Radiopharmaceutical Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Oncology Radiopharmaceutical Sales by Region (2018-2024) & (K Units)
Table 18. Global Oncology Radiopharmaceutical Sales Market Share by Region (2018-2024)
Table 19. Global Oncology Radiopharmaceutical Sales by Region (2024-2034) & (K Units)
Table 20. Global Oncology Radiopharmaceutical Sales Market Share by Region (2024-2034)
Table 21. Global Oncology Radiopharmaceutical Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Oncology Radiopharmaceutical Revenue Market Share by Region (2018-2024)
Table 23. Global Oncology Radiopharmaceutical Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Oncology Radiopharmaceutical Revenue Market Share by Region (2024-2034)
Table 25. North America Oncology Radiopharmaceutical Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Oncology Radiopharmaceutical Sales by Country (2018-2024) & (K Units)
Table 27. North America Oncology Radiopharmaceutical Sales by Country (2024-2034) & (K Units)
Table 28. North America Oncology Radiopharmaceutical Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Oncology Radiopharmaceutical Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Oncology Radiopharmaceutical Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Oncology Radiopharmaceutical Sales by Country (2018-2024) & (K Units)
Table 32. Europe Oncology Radiopharmaceutical Sales by Country (2024-2034) & (K Units)
Table 33. Europe Oncology Radiopharmaceutical Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Oncology Radiopharmaceutical Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Oncology Radiopharmaceutical Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Oncology Radiopharmaceutical Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Oncology Radiopharmaceutical Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Oncology Radiopharmaceutical Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Oncology Radiopharmaceutical Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Oncology Radiopharmaceutical Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Oncology Radiopharmaceutical Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Oncology Radiopharmaceutical Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Oncology Radiopharmaceutical Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Oncology Radiopharmaceutical Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Oncology Radiopharmaceutical Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Oncology Radiopharmaceutical Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Oncology Radiopharmaceutical Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Oncology Radiopharmaceutical Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Oncology Radiopharmaceutical Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Oncology Radiopharmaceutical Sales (K Units) by Type (2018-2024)
Table 51. Global Oncology Radiopharmaceutical Sales (K Units) by Type (2024-2034)
Table 52. Global Oncology Radiopharmaceutical Sales Market Share by Type (2018-2024)
Table 53. Global Oncology Radiopharmaceutical Sales Market Share by Type (2024-2034)
Table 54. Global Oncology Radiopharmaceutical Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Oncology Radiopharmaceutical Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Oncology Radiopharmaceutical Revenue Market Share by Type (2018-2024)
Table 57. Global Oncology Radiopharmaceutical Revenue Market Share by Type (2024-2034)
Table 58. Global Oncology Radiopharmaceutical Price (US$/Unit) by Type (2018-2024)
Table 59. Global Oncology Radiopharmaceutical Price (US$/Unit) by Type (2024-2034)
Table 60. Global Oncology Radiopharmaceutical Sales (K Units) by Application (2018-2024)
Table 61. Global Oncology Radiopharmaceutical Sales (K Units) by Application (2024-2034)
Table 62. Global Oncology Radiopharmaceutical Sales Market Share by Application (2018-2024)
Table 63. Global Oncology Radiopharmaceutical Sales Market Share by Application (2024-2034)
Table 64. Global Oncology Radiopharmaceutical Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Oncology Radiopharmaceutical Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Oncology Radiopharmaceutical Revenue Market Share by Application (2018-2024)
Table 67. Global Oncology Radiopharmaceutical Revenue Market Share by Application (2024-2034)
Table 68. Global Oncology Radiopharmaceutical Price (US$/Unit) by Application (2018-2024)
Table 69. Global Oncology Radiopharmaceutical Price (US$/Unit) by Application (2024-2034)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Novartis Oncology Radiopharmaceutical Product
Table 74. Novartis Recent Developments/Updates
Table 75. Chimeric Therapeutics Limited Corporation Information
Table 76. Chimeric Therapeutics Limited Description and Business Overview
Table 77. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product
Table 79. Chimeric Therapeutics Limited Recent Developments/Updates
Table 80. Fusion Pharma Corporation Information
Table 81. Fusion Pharma Description and Business Overview
Table 82. Fusion Pharma Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Fusion Pharma Oncology Radiopharmaceutical Product
Table 84. Fusion Pharma Recent Developments/Updates
Table 85. Lantheus Medical lmaging, Inc. Corporation Information
Table 86. Lantheus Medical lmaging, Inc. Description and Business Overview
Table 87. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product
Table 89. Lantheus Medical lmaging, Inc. Recent Developments/Updates
Table 90. NanoMab Corporation Information
Table 91. NanoMab Description and Business Overview
Table 92. NanoMab Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. NanoMab Oncology Radiopharmaceutical Product
Table 94. NanoMab Recent Developments/Updates
Table 95. NuView Life Sciences. Corporation Information
Table 96. NuView Life Sciences. Description and Business Overview
Table 97. NuView Life Sciences. Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. NuView Life Sciences. Oncology Radiopharmaceutical Product
Table 99. NuView Life Sciences. Recent Developments/Updates
Table 100. PentixaPharm GmbHPrecirix Corporation Information
Table 101. PentixaPharm GmbHPrecirix Description and Business Overview
Table 102. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product
Table 104. PentixaPharm GmbHPrecirix Recent Developments/Updates
Table 105. RadioMedix Corporation Information
Table 106. RadioMedix Description and Business Overview
Table 107. RadioMedix Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. RadioMedix Oncology Radiopharmaceutical Product
Table 109. RadioMedix Recent Developments/Updates
Table 110. RayzeBio Corporation Information
Table 111. RayzeBio Description and Business Overview
Table 112. RayzeBio Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. RayzeBio Oncology Radiopharmaceutical Product
Table 114. RayzeBio Recent Developments/Updates
Table 115. Telix Pharmaceuticals Limited Corporation Information
Table 116. Telix Pharmaceuticals Limited Description and Business Overview
Table 117. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product
Table 119. Telix Pharmaceuticals Limited Recent Developments/Updates
Table 120. Theragnostics Ltd Corporation Information
Table 121. Theragnostics Ltd Description and Business Overview
Table 122. Theragnostics Ltd Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Theragnostics Ltd Oncology Radiopharmaceutical Product
Table 124. Theragnostics Ltd Recent Developments/Updates
Table 125. Vect-Horus Corporation Information
Table 126. Vect-Horus Description and Business Overview
Table 127. Vect-Horus Oncology Radiopharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Vect-Horus Oncology Radiopharmaceutical Product
Table 129. Vect-Horus Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Oncology Radiopharmaceutical Distributors List
Table 133. Oncology Radiopharmaceutical Customers List
Table 134. Oncology Radiopharmaceutical Market Trends
Table 135. Oncology Radiopharmaceutical Market Drivers
Table 136. Oncology Radiopharmaceutical Market Challenges
Table 137. Oncology Radiopharmaceutical Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oncology Radiopharmaceutical
Figure 2. Global Oncology Radiopharmaceutical Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Oncology Radiopharmaceutical Market Share by Type in 2022 & 2034
Figure 4. Oral Drugs Product Picture
Figure 5. Intravenous Drugs Product Picture
Figure 6. Other Product Picture
Figure 7. Global Oncology Radiopharmaceutical Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Oncology Radiopharmaceutical Market Share by Application in 2022 & 2034
Figure 9. Hospitals and Clinics
Figure 10. Pharmaceutical Company
Figure 11. Research Center
Figure 12. Other
Figure 13. Global Oncology Radiopharmaceutical Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Oncology Radiopharmaceutical Market Size (2018-2034) & (US$ Million)
Figure 15. Global Oncology Radiopharmaceutical Sales (2018-2034) & (K Units)
Figure 16. Global Oncology Radiopharmaceutical Average Price (US$/Unit) & (2018-2034)
Figure 17. Oncology Radiopharmaceutical Report Years Considered
Figure 18. Oncology Radiopharmaceutical Sales Share by Manufacturers in 2022
Figure 19. Global Oncology Radiopharmaceutical Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Oncology Radiopharmaceutical Players: Market Share by Revenue in 2022
Figure 21. Oncology Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Oncology Radiopharmaceutical Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 23. North America Oncology Radiopharmaceutical Sales Market Share by Country (2018-2034)
Figure 24. North America Oncology Radiopharmaceutical Revenue Market Share by Country (2018-2034)
Figure 25. United States Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Canada Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Europe Oncology Radiopharmaceutical Sales Market Share by Country (2018-2034)
Figure 28. Europe Oncology Radiopharmaceutical Revenue Market Share by Country (2018-2034)
Figure 29. Germany Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. France Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. U.K. Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Italy Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Russia Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Asia Pacific Oncology Radiopharmaceutical Sales Market Share by Region (2018-2034)
Figure 35. Asia Pacific Oncology Radiopharmaceutical Revenue Market Share by Region (2018-2034)
Figure 36. China Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Japan Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. South Korea Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. India Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Australia Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. China Taiwan Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Southeast Asia Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Oncology Radiopharmaceutical Sales Market Share by Country (2018-2034)
Figure 44. Latin America Oncology Radiopharmaceutical Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Oncology Radiopharmaceutical Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Oncology Radiopharmaceutical Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Oncology Radiopharmaceutical Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Oncology Radiopharmaceutical by Type (2018-2034)
Figure 54. Global Revenue Market Share of Oncology Radiopharmaceutical by Type (2018-2034)
Figure 55. Global Oncology Radiopharmaceutical Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Oncology Radiopharmaceutical by Application (2018-2034)
Figure 57. Global Revenue Market Share of Oncology Radiopharmaceutical by Application (2018-2034)
Figure 58. Global Oncology Radiopharmaceutical Price (US$/Unit) by Application (2018-2034)
Figure 59. Oncology Radiopharmaceutical Value Chain
Figure 60. Oncology Radiopharmaceutical Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed